| Ytd | 19.32% | |
| 1y | 80.07% |
| Open | 5.21 | Prev Close | 5.27 | Low | 4.80 | High | 5.26 | Mkt Cap | 1.80B |
| Vol | 8.20M | Avg Vol | 7.01M | EPS | -2.84 | P/E | N/A | Forward P/E | -10.72 |
| Beta | 1.60 | Short Ratio | 4.63 | Inst. Own | 43.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 4.30 | 200-d Avg | 4.29 | 1yr Est | 14.00 |
ATAI is now a more focused psychedelics biotech. Particularly, BPL-003 is their main bet on TRD's si
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) announced on Thursday that it will be added to the Russell
Blackberry (TSX:BB) shares jumped nearly 21% on Thursday in New York and Toronto after the Canadian
The Russell U.S. Indexes have approximately $12.2 trillion in assets benchmarkedInclusion expands At
AtaiBeckley to be added to the Russell 2000® Index and the broad-market Russell 3000® Index as part
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates AtaiBeckley (NASDAQ:ATAI) with a B